On the other hand, it takes only one successful trial to realistically expect a SP of over 5$. IHL has a unique story when compared to other stocks that’s why its chart attracts new investors even without knowing the fundamentals. BOD see the inside story, if they paid millions out of their pockets then I am not selling a single until BOD starts selling or a big pharma takes over. We are less than 2 years away from an FDA approval. Meanwhile let the SP go up or down I don’t care.
IHL Price at posting:
62.5¢ Sentiment: Hold Disclosure: Held